Skip to content

Quality of Life and Sexual Function of Vaginal Operation in The Treatment Of Previous Cesarean Scar Defect

Safety ,Validity and Quality of (Sexual)Life of Vaginal Operation in The Treatment Of Previous Cesarean Scar Defect

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01978067
Acronym
PCSD
Enrollment
60
Registered
2013-11-07
Start date
2013-01-31
Completion date
2015-12-31
Last updated
2014-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Sexual Activity

Keywords

Uterine Scar From Previous Cesarean Delivery, previous caesarean scar deficiency, transvaginal resection, quality of life, sexual activity

Brief summary

The aim of this study is to further demonstrate the safety , validity and quality of (sexual)life of vaginal operation for previous cesarean scar defect resection.

Detailed description

collect all the patients'clinical information,use two questionnaire (the HRQoL and FSFI)to estimate patients' general healthy and sexual function before surgery and postoperation in 1 month,3 months and 6 months

Interventions

PROCEDUREtransvaginal resection of Uterine Scar

Expose, grasp and traction the cervix. An incision was made at the anterior cervicovaginal junction, and the bladder was dissected away until the anterior peritoneal reflection was identified. The anterior drawing hook was inserted.into the vaginal incision to retract the bladder upwards. The PCSD was identified as a'fornix' located in the anterior part of the lower uterine segment. A transverse incision was made to remove the scar deficiency, and the edges of the incision were trimmed with scissors, and the myometrial and vaginal defects were closed.

Sponsors

Shu-Qin Chen
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* preoperative diagnosed as PCSD * hemodynamic stability

Exclusion criteria

* irregular menstrual cycle * using IUD * complicating other disease also causing vaginal bleeding,such as endometrial polyp,submucous myoma and functional uterine bleeding.

Design outcomes

Primary

MeasureTime frameDescription
The safety of transvaginal resection of caesarean scar deficiency in the treatment of PCSDone weekblood loss, hemoglobin in the first postoperative day, operation time, preoperative and postoperative complications,change to other treatment,vaginal bleeding after surgery and length of stay are collected to evaluate the safety of this procedure.

Secondary

MeasureTime frameDescription
the effectiveness of transvaginal resection of caesarean scar deficiency in the treatment of PCSD.one yearObservation of menstruation in three months,six months and nine months after surgery is applied for evaluating the effectiveness of this procedure and transvaginal ultrasound,hysteroscopy and Gynecological Examination are performed after surgery.Situation of fertility ,(sex)quality of life after surgery also are very important indicator of this procedure effectiveness

Other

MeasureTime frameDescription
the result of transvaginal resection of caesarean scar deficiency in affecting quality of (sex)life.one yeartwo questionnaires results:FSFI and HRQoL

Countries

China

Contacts

Primary ContactChen Shu-Qin, PhD & MD
chenshuqin1021@163.com+862087332200
Backup ContactFan Li, M.D
37488373@qq.com+862087332200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026